| 
						
						
						 One 
						in seven U.S. adults used marijuana in 2017 
   Send a link to a friend 
		[August 28, 2018]  
		By Linda Carroll
 (Reuters Health) - With more and more 
		states legalizing marijuana, whether for medical use, recreational use, 
		or both, increasing numbers of Americans are using cannabis. A new 
		survey finds that one in seven had used marijuana in 2017, with smoking 
		being the most common manner of consumption, according to a report 
		published in the Annals of Internal Medicine.
 | 
        
            | 
			
			 People were more likely to vape or to consume marijuana as an edible 
			in states where recreational use has been legalized, researchers 
			found in the nationally representative survey of 16,280 U.S. adults. 
 Overall, 14.6 percent said they had used cannabis in the past year, 
			while 8.7 percent said they had used the drug in the past 30 days. A 
			greater proportion of people, 20 percent, reported using marijuana 
			in the past year if they lived in a state where recreational use was 
			legal, as compared to just 12 percent in states where it was 
			completely illegal. In states where medical marijuana was legal, 14 
			percent of those surveyed said they had used in the past year.
 
 While 12.9 percent reported smoking marijuana, 6 percent said they 
			had consumed edibles, 4.7 percent reported vaping, 1.9 percent said 
			they had used concentrates and 0.8 percent reported using topical 
			versions of cannabis.
 
 "There are increasingly novel forms of marijuana available and the 
			risks of these products to health are unknown," said study coauthor 
			Dr. Salomeh Keyhani of the University of California, San Francisco. 
			"THC (the psychoactive component) is very high in some forms of 
			marijuana, the concentrates, for example. We don't understand the 
			impact of products with high THC."
 
 Keyhani is concerned about the rapidly changing landscape. "It seems 
			like the current regulatory structure is not keeping pace with 
			commercialization," she said. "There is commercialization without 
			uniform standards on the types of products that can be sold or 
			marketed to the public."
 
 Cannabis use was inversely related to age. Younger people were more 
			likely than older ones to use, with those between 18 and 34 
			reporting the highest use.
 
			
			 
			Smoking was the most common form of cannabis use, at 55 percent.
 Baked goods or pastries and candy were the most common forms of 
			edibles consumed by U.S. adults.
 
 Keyhani is right to be concerned about the varying levels of THC in 
			the cannabis products people are using, said Dr. Michael Lynch, an 
			emergency physician and toxicologist and medical director of the 
			Pittsburgh Poison Center of the University of Pittsburgh Medical 
			Center.
 
			
            [to top of second column] | 
 
			"Historically the downsides of marijuana have been minimized," Lynch 
			said. "Its use has been considered to be safe and without risks and 
			that is not necessarily the case. For example, 10 percent of adult 
			users become addicted, while about 17 percent of adolescent users 
			do. Those are not insignificant numbers when you consider that the 
			overall numbers are increasing."
 What's most concerning, Lynch said, are products with high 
			concentrations of THC, whether it's in oils for vaping or in 
			edibles. "When it's more concentrated or more highly potent, you see 
			side effects like agitation," he added. "There's a potential for 
			anxiety and for psychotic effects."
 
			
			 
			And while there's talk about cannabis calming seizures, in high 
			potency forms it can actually bring them on in people who are 
			vulnerable, Lynch said.
 Lynch is also concerned about teen use. "Early use is associated 
			with more negative effects on brain and cognitive development," he 
			said.
 
 Ultimately, there needs to be more research on cannabis, and a way 
			to know what potency marijuana you're getting, Lynch said.
 
 "In states like Pennsylvania, where medical marijuana is legal, it's 
			tightly regulated in terms of concentrations," he said. "So what's 
			on the label ought to be correct."
 
 As for risks and benefits, that's "a moving target," Lynch said.
 
 SOURCE: http://bit.ly/2wYH0qu Annals of Internal Medicine, online 
			August 27, 2018.
 
			[© 2018 Thomson Reuters. All rights 
				reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. 
			
			
			 |